{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:22:15Z","timestamp":1789024935984,"version":"build-2803163510"},"reference-count":113,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.mcna.2021.06.008","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T04:37:05Z","timestamp":1631075825000},"page":"1099-1116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Practical Approach to Hyperandrogenism in Women"],"prefix":"10.1016","volume":"105","author":[{"given":"Anu","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrine K.","family":"Welt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mcna.2021.06.008_bib1","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1210\/jc.2018-00241","article-title":"Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline","volume":"103","author":"Martin","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2021.06.008_bib2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mce.2017.06.026","article-title":"Role of androgens in the ovary","volume":"465","author":"Walters","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.mcna.2021.06.008_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mce.2017.08.016","article-title":"Intracrine androgen biosynthesis, metabolism and action revisited","volume":"465","author":"Schiffer","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"02","key":"10.1016\/j.mcna.2021.06.008_bib4","doi-asserted-by":"crossref","first-page":"071","DOI":"10.1055\/s-2006-939565","article-title":"Androgen Physiology","volume":"24","author":"Davison","year":"2006","journal-title":"Semin Reprod Med"},{"issue":"Suppl 4","key":"10.1016\/j.mcna.2021.06.008_bib5","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0015-0282(02)02985-0","article-title":"Androgen production in women","volume":"77","author":"Burger","year":"2002","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.mcna.2021.06.008_bib6","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1210\/jcem-72-5-1088","article-title":"Metabolic Clearance Rate of Dehydroepiandrosterone Sulfate, Its Metabolism to Testosterone, and Its Intrafollicular Metabolism to Dehydroepiandrosterone, Androstenedione, Testosterone, and Dihydrotestosterone in\u00a0Vivo\u2217","volume":"72","author":"Haning","year":"1991","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.008_bib7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1073\/pnas.0506736102","article-title":"Premature ovarian failure in androgen receptor-deficient mice","volume":"103","author":"Shiina","year":"2006","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"6","key":"10.1016\/j.mcna.2021.06.008_bib8","doi-asserted-by":"crossref","first-page":"E717","DOI":"10.1152\/ajpendo.00263.2013","article-title":"Characterizing the neuroendocrine and ovarian defects of androgen receptor-knockout female mice","volume":"305","author":"Cheng","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.mcna.2021.06.008_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1095\/biolreprod.112.102012","article-title":"Targeted loss of androgen receptor signaling in murine granulosa cells of preantral and antral follicles causes female subfertility","volume":"87","author":"Walters","year":"2012","journal-title":"Biol Reprod"},{"issue":"10","key":"10.1016\/j.mcna.2021.06.008_bib10","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1210\/me.2014-1154","article-title":"Conditional knockout of the androgen receptor in gonadotropes reveals crucial roles for androgen in gonadotropin synthesis and surge in female mice","volume":"28","author":"Wu","year":"2014","journal-title":"Mol Endocrinol"},{"issue":"4","key":"10.1016\/j.mcna.2021.06.008_bib11","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2265.1990.tb03887.x","article-title":"The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives","volume":"33","author":"Hague","year":"1990","journal-title":"Clin Endocrinol"},{"issue":"7","key":"10.1016\/j.mcna.2021.06.008_bib12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.endoen.2014.06.012","article-title":"Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals","volume":"61","author":"Becerra-Fern\u00e1ndez","year":"2014","journal-title":"Endocrinolog\u00eda y Nutrici\u00f3n (English Edition)"},{"issue":"10","key":"10.1016\/j.mcna.2021.06.008_bib13","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1093\/humrep\/deq220","article-title":"Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: A randomized prospective study","volume":"25","author":"Wiser","year":"2010","journal-title":"Humanit Rep"},{"issue":"2","key":"10.1016\/j.mcna.2021.06.008_bib14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.fertnstert.2010.07.1077","article-title":"The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders","volume":"95","author":"Kim","year":"2011","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.008_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ecl.2020.10.006","article-title":"Genetics of polycystic ovary syndrome: What is new?","volume":"50","author":"Welt","year":"2021","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"10.1016\/j.mcna.2021.06.008_bib16","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1210\/jc.2005-1494","article-title":"Heritability of polycystic ovary syndrome in a Dutch twin-family study","volume":"91","author":"Vink","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.mcna.2021.06.008_bib17","doi-asserted-by":"crossref","first-page":"e1007813","DOI":"10.1371\/journal.pgen.1007813","article-title":"Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria","volume":"14","author":"Day","year":"2018","journal-title":"Plos Genet"},{"issue":"2","key":"10.1016\/j.mcna.2021.06.008_bib18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41591-020-0751-5","article-title":"Using human genetics to understand the disease impacts of testosterone in men and women","volume":"26","author":"Ruth","year":"2020","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.008_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng.732","article-title":"Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3","volume":"43","author":"Chen","year":"2011","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.mcna.2021.06.008_bib20","first-page":"146","article-title":"Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"18","author":"Escobar-Morreale","year":"2011","journal-title":"Humanit Rep"},{"issue":"7","key":"10.1016\/j.mcna.2021.06.008_bib21","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/jamadermatol.2016.0358","article-title":"Clinician vs Self-ratings of Hirsutism in Patients With Polycystic Ovarian Syndrome: Associations With Quality of Life and Depression","volume":"152","author":"Pasch","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"11","key":"10.1016\/j.mcna.2021.06.008_bib22","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1373\/clinchem.2018.290825","article-title":"Diagnostic Thresholds for Androgen-Producing Tumors or Pathologic Hyperandrogenism in Women by Use of Total Testosterone Concentrations Measured by Liquid Chromatography-Tandem Mass Spectrometry","volume":"64","author":"Sharma","year":"2018","journal-title":"Clin Chem"},{"issue":"24","key":"10.1016\/j.mcna.2021.06.008_bib23","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1056\/NEJMcp033496","article-title":"Clinical practice","volume":"353","author":"Rosenfield","year":"2005","journal-title":"Hirsutism N Engl J Med"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.008_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijwd.2017.01.006","article-title":"Association of ethnicity, Fitzpatrick skin type, and hirsutism: A retrospective cross-sectional study of women with polycystic ovarian syndrome","volume":"3","author":"Afifi","year":"2017","journal-title":"Int J Womens Dermatol"},{"issue":"7","key":"10.1016\/j.mcna.2021.06.008_bib25","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1210\/jc.2004-2243","article-title":"Ferriman Gallwey self-scoring I: performance assessment in women with polycystic ovary syndrome","volume":"90","author":"Wild","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.008_bib26","first-page":"51","article-title":"Visually scoring hirsutism","volume":"16","author":"Yildiz","year":"2010","journal-title":"Humanit Rep"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.008_bib27","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s13256-017-1411-3","article-title":"Postmenopausal mild hirsutism and hyperandrogenemia due to granulosa cell tumor of the ovary: a case report","volume":"11","author":"Adefris","year":"2017","journal-title":"J\u00a0Med Case Rep"},{"issue":"7","key":"10.1016\/j.mcna.2021.06.008_bib28","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1210\/jc.2018-02548","article-title":"Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee","volume":"104","author":"Carmina","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.008_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.1990.tb03744.x","article-title":"Plasma C19 steroid sulphate levels and indices of androgen bioavailability in female pattern androgenic alopecia","volume":"32","author":"Montalto","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.008_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00403-017-1798-0","article-title":"5\u03b1-Reductase isozymes and aromatase mRNA levels in plucked hair from young women with female pattern hair loss","volume":"310","author":"S\u00e1nchez","year":"2018","journal-title":"Arch Dermatol Res"},{"issue":"12","key":"10.1016\/j.mcna.2021.06.008_bib31","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s004030000184","article-title":"Role of androgens in female-pattern androgenetic alopecia, either alone or associated with other symptoms of hyperandrogenism","volume":"292","author":"Vexiau","year":"2000","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.008_bib32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/md.0b013e3181946a2c","article-title":"Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism","volume":"88","author":"Karrer-Voegeli","year":"2009","journal-title":"Medicine (Baltimore)"},{"issue":"5 Pt 1","key":"10.1016\/j.mcna.2021.06.008_bib33","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0190-9622(88)70241-8","article-title":"The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia","volume":"19","author":"Futterweit","year":"1988","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.mcna.2021.06.008_bib34","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2133.2006.07671.x","article-title":"Testosterone metabolism to 5alpha-dihydrotestosterone and synthesis of sebaceous lipids is regulated by the peroxisome proliferator-activated receptor ligand linoleic acid in human sebocytes","volume":"156","author":"Makrantonaki","year":"2007","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.mcna.2021.06.008_bib35","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1046\/j.1523-1747.2003.12244.x","article-title":"Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1)","volume":"120","author":"Thiboutot","year":"2003","journal-title":"J\u00a0Invest Dermatol"},{"issue":"2","key":"10.1016\/j.mcna.2021.06.008_bib36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.clindermatol.2016.10.004","article-title":"Sex hormones and acne","volume":"35","author":"Ju","year":"2017","journal-title":"Clin Dermatol"},{"issue":"4","key":"10.1016\/j.mcna.2021.06.008_bib37","doi-asserted-by":"crossref","first-page":"976.e13-5","DOI":"10.1016\/j.fertnstert.2006.07.1547","article-title":"Postmenopausal virilization after spousal use of topical androgens","volume":"87","author":"Merhi","year":"2007","journal-title":"Fertil Steril"},{"issue":"12","key":"10.1016\/j.mcna.2021.06.008_bib38","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1001\/jamainternmed.2017.5141","article-title":"Compounded Bioidentical Hormone Therapy: Does the Regulatory Double Standard Harm Women?","volume":"177","author":"Stuenkel","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.mcna.2021.06.008_bib39","first-page":"562","article-title":"The clitoral index: a bioassay of androgenic stimulation","volume":"54","author":"Tagatz","year":"1979","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.mcna.2021.06.008_bib40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","article-title":"Utility, Limitations, and Pitfalls in Measuring Testosterone: An Endocrine Society Position Statement","volume":"92","author":"Rosner","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.mcna.2021.06.008_bib41","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1210\/jc.2010-1123","article-title":"Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism","volume":"95","author":"Legro","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.mcna.2021.06.008_bib42","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.fertnstert.2005.01.096","article-title":"Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups","volume":"83","author":"Chang","year":"2005","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.mcna.2021.06.008_bib43","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1210\/jcem-32-6-717","article-title":"Plasma testosterone binding globulin and indexes of the concentration of unbound plasma androgens in normal and hirsute subjects","volume":"32","author":"Rosenfield","year":"1971","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.mcna.2021.06.008_bib44","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2017-00025","article-title":"A\u00a0Reappraisal of Testosterone's Binding in Circulation: Physiological and Clinical Implications","volume":"38","author":"Goldman","year":"2017","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.mcna.2021.06.008_bib45","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/db11-0727","article-title":"Potential role of tumor necrosis factor-\u03b1 in downregulating sex hormone-binding globulin","volume":"61","author":"Sim\u00f3","year":"2012","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.008_bib46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1210\/jcem-72-1-83","article-title":"A\u00a0direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome","volume":"72","author":"Nestler","year":"1991","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.mcna.2021.06.008_bib47","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1172\/JCI0214060","article-title":"Human sex hormone-binding globulin variants associated with hyperandrogenism and ovarian dysfunction","volume":"109","author":"Hogeveen","year":"2002","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.mcna.2021.06.008_bib48","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1210\/jc.2017-02426","article-title":"Causes, Patterns, and Severity of Androgen Excess in 1205 Consecutively Recruited Women","volume":"103","author":"Elhassan","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.mcna.2021.06.008_bib49","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1210\/jc.2006-1191","article-title":"Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations","volume":"91","author":"Welt","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.mcna.2021.06.008_bib50","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jc.2013-3399","article-title":"Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione","volume":"99","author":"O'Reilly","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.mcna.2021.06.008_bib51","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s12020-014-0200-7","article-title":"Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome","volume":"47","author":"Livadas","year":"2014","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.008_bib52","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1365-2265.2003.01792.x","article-title":"Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?","volume":"59","author":"Kaltsas","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.mcna.2021.06.008_bib53","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1148\/radiographics.18.6.9821198","article-title":"Sex cord-stromal and steroid cell tumors of the ovary","volume":"18","author":"Outwater","year":"1998","journal-title":"Radiographics"},{"issue":"2","key":"10.1016\/j.mcna.2021.06.008_bib54","doi-asserted-by":"crossref","first-page":"753.e11-4","DOI":"10.1016\/j.fertnstert.2010.01.035","article-title":"Use of F 18-fluoro-D-glucose-positron emission tomography-computed tomography to localize a hilar cell tumor of the ovary","volume":"94","author":"McCarthy-Keith","year":"2010","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.mcna.2021.06.008_bib55","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3109\/09513590.2010.521263","article-title":"Leydig cell tumour of the ovary localised with positron emission tomography\/computed tomography","volume":"27","author":"Prassopoulos","year":"2011","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.008_bib56","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1530\/EJE-17-0111","article-title":"Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies","volume":"177","author":"Yance","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2021.06.008_bib57","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1148\/rg.24si045501","article-title":"Functioning ovarian tumors: direct and indirect findings at MR imaging","volume":"24","author":"Tanaka","year":"2004","journal-title":"Radiographics"},{"issue":"3","key":"10.1016\/j.mcna.2021.06.008_bib58","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.mcna.2021.06.008_bib59","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1148\/rg.2020190080","article-title":"Technical and Interpretive Pitfalls in Adrenal Imaging","volume":"40","author":"Nandra","year":"2020","journal-title":"Radiographics"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.008_bib60","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/cen.13448","article-title":"Diagnostic performance of unenhanced computed tomography and (18) F-fluorodeoxyglucose positron emission tomography in indeterminate adrenal tumours","volume":"88","author":"Delivanis","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.mcna.2021.06.008_bib61","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.mcna.2021.06.008_bib62","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ecl.2018.02.005","article-title":"Mortality in Patients with Endogenous Cushing's Syndrome","volume":"47","author":"Javanmard","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1053","key":"10.1016\/j.mcna.2021.06.008_bib63","doi-asserted-by":"crossref","first-page":"20150352","DOI":"10.1259\/bjr.20150352","article-title":"Imaging features of poorly controlled congenital adrenal hyperplasia in adults","volume":"88","author":"Kok","year":"2015","journal-title":"Br J Radiol"},{"issue":"12","key":"10.1016\/j.mcna.2021.06.008_bib64","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Humanit Rep"},{"issue":"2","key":"10.1016\/j.mcna.2021.06.008_bib65","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.008_bib66","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2005-1457","article-title":"Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism","volume":"91","author":"Carmina","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.mcna.2021.06.008_bib67","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.mcna.2021.06.008_bib68","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2265.1994.tb02535.x","article-title":"A\u00a0prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia","volume":"41","author":"O'Driscoll","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.mcna.2021.06.008_bib69","first-page":"347","article-title":"Idiopathic hirsutism","volume":"21","author":"Azziz","year":"2000","journal-title":"Endocr Rev"},{"issue":"13","key":"10.1016\/j.mcna.2021.06.008_bib70","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJMra1909786","article-title":"Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency","volume":"383","author":"Merke","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"5 Pt 2","key":"10.1016\/j.mcna.2021.06.008_bib71","first-page":"893","article-title":"Postmenopausal hyperthecosis: functional dysregulation of androgenesis in climacteric ovary","volume":"99","author":"Krug","year":"2002","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.mcna.2021.06.008_bib72","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1530\/EJE-14-0468","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: Hyperandrogenism after menopause","volume":"172","author":"Markopoulos","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.mcna.2021.06.008_bib73","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/uog.6131","article-title":"Ovarian hyperthecosis on grayscale and color Doppler ultrasound","volume":"32","author":"Rousset","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"15","key":"10.1016\/j.mcna.2021.06.008_bib74","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1056\/NEJM199410133311502","article-title":"Identification of virilizing adrenal tumors in hirsute women","volume":"331","author":"Derksen","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.mcna.2021.06.008_bib75","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1210\/jc.2019-01603","article-title":"Global Consensus Position Statement on the Use of Testosterone Therapy for Women","volume":"104","author":"Davis","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1\u20132","key":"10.1016\/j.mcna.2021.06.008_bib76","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.eplepsyres.2011.07.006","article-title":"A\u00a0meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy","volume":"97","author":"Hu","year":"2011","journal-title":"Epilepsy Res"},{"issue":"9","key":"10.1016\/j.mcna.2021.06.008_bib77","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/j.1528-1167.2006.00506.x","article-title":"Effects of carbamazepine and oxcarbazepine on the reproductive endocrine function in women with epilepsy","volume":"47","author":"L\u00f6fgren","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.mcna.2021.06.008_bib78","doi-asserted-by":"crossref","unstructured":"Hakim C, Padmanabhan V, Vyas AK. Gestational Hyperandrogenism in Developmental Programming. Endocrinology 2017;158(2):199-212.","DOI":"10.1210\/en.2016-1801"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.008_bib79","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.rbmo.2013.03.009","article-title":"Reproductive hormone concentrations in pregnancy and neonates: a systematic review","volume":"27","author":"Kuijper","year":"2013","journal-title":"Reprod Biomed Online"},{"issue":"10","key":"10.1016\/j.mcna.2021.06.008_bib80","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1093\/humrep\/17.10.2573","article-title":"Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization","volume":"17","author":"Sir-Petermann","year":"2002","journal-title":"Humanit Rep"},{"issue":"5","key":"10.1016\/j.mcna.2021.06.008_bib81","doi-asserted-by":"crossref","first-page":"543.e1-9","DOI":"10.1016\/j.ajog.2007.11.012","article-title":"Androgen-regulated cervical ripening: a structural, biomechanical, and molecular analysis","volume":"198","author":"Ji","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.mcna.2021.06.008_bib82","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1095\/biolreprod.104.036954","article-title":"Androgens induce relaxation of contractile activity in pregnant human myometrium at term: a nongenomic action on L-type calcium channels","volume":"73","author":"Perusqu\u00eda","year":"2005","journal-title":"Biol Reprod"},{"issue":"2","key":"10.1016\/j.mcna.2021.06.008_bib83","doi-asserted-by":"crossref","first-page":"243","DOI":"10.33549\/physiolres.932078","article-title":"Hyperandrogenic states in pregnancy","volume":"60","author":"Ka\u0148ov\u00e1","year":"2011","journal-title":"Physiol Res"},{"issue":"2","key":"10.1016\/j.mcna.2021.06.008_bib84","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1530\/ror.0.0030130","article-title":"Sexual differentiation of reproductive neuroendocrine function in sheep","volume":"3","author":"Wood","year":"1998","journal-title":"Rev Reprod"},{"issue":"2","key":"10.1016\/j.mcna.2021.06.008_bib85","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1530\/eje.1.02200","article-title":"Maternal testosterone levels during pregnancy are associated with offspring size at birth","volume":"155","author":"Carlsen","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.mcna.2021.06.008_bib86","first-page":"1206","article-title":"Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys","volume":"85","author":"Eisner","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2021.06.008_bib87","doi-asserted-by":"crossref","first-page":"28335","DOI":"10.1038\/srep28335","article-title":"Prenatal programming: adverse cardiac programming by gestational testosterone excess","volume":"6","author":"Vyas","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.mcna.2021.06.008_bib88","first-page":"357","article-title":"Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?","volume":"11","author":"Abbott","year":"2005","journal-title":"Humanit Rep"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.008_bib89","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.yhbeh.2006.02.006","article-title":"Androgens and autistic traits: A study of individuals with congenital adrenal hyperplasia","volume":"50","author":"Knickmeyer","year":"2006","journal-title":"Horm Behav"},{"issue":"9477","key":"10.1016\/j.mcna.2021.06.008_bib90","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(05)66736-0","article-title":"Congenital adrenal hyperplasia","volume":"365","author":"Merke","year":"2005","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.mcna.2021.06.008_bib91","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/OGX.0b013e3181f8c41d","article-title":"Pregnancy luteomas: clinical presentations and management strategies","volume":"65","author":"Masarie","year":"2010","journal-title":"Obstet Gynecol Surv"},{"issue":"3","key":"10.1016\/j.mcna.2021.06.008_bib92","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/jog.12253","article-title":"Long-term oncological and reproductive outcomes of fertility-sparing cytoreductive surgery in females aged 25 years and younger with malignant ovarian germ cell tumors","volume":"40","author":"Ertas","year":"2014","journal-title":"J\u00a0Obstet Gynaecol Res"},{"issue":"7","key":"10.1016\/j.mcna.2021.06.008_bib93","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jvir.2016.03.042","article-title":"Clinical Outcomes following Percutaneous Radiofrequency Ablation of Unilateral Aldosterone-Producing Adenoma: Comparison with Adrenalectomy","volume":"27","author":"Sarwar","year":"2016","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.mcna.2021.06.008_bib94","first-page":"1","article-title":"Computed tomography-guided cryoablation for functional adrenal aldosteronoma","author":"Fu","year":"2019","journal-title":"Minim Invasive Ther Allied Technol"},{"issue":"3","key":"10.1016\/j.mcna.2021.06.008_bib95","first-page":"Cd007506","article-title":"Lifestyle changes in women with polycystic ovary syndrome","volume":"3","author":"Lim","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.mcna.2021.06.008_bib96","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.mcna.2021.06.008_bib97","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0015-0282(99)00146-6","article-title":"Effect of age on the response of the hypothalamo-pituitary-ovarian axis to a combined oral contraceptive","volume":"71","author":"Fitzgerald","year":"1999","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.mcna.2021.06.008_bib98","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/13625180008500402","article-title":"The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives","volume":"5","author":"Nightingale","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"3","key":"10.1016\/j.mcna.2021.06.008_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6503a1","article-title":"U.S. Medical Eligibility Criteria for Contraceptive Use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"10.1016\/j.mcna.2021.06.008_bib100","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1210\/jc.2007-2430","article-title":"Clinical review: Antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials","volume":"93","author":"Swiglo","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.008_bib101","first-page":"19","article-title":"Finasteride for hirsutism: a dose finding study","volume":"19","author":"Al-Khawajah","year":"1998","journal-title":"Saudi Med J"},{"issue":"11","key":"10.1016\/j.mcna.2021.06.008_bib102","article-title":"Sexual side effects of 5-\u03b1-reductase inhibitors finasteride and dutasteride: A comprehensive review","volume":"23","author":"Fertig","year":"2017","journal-title":"Dermatol Online J"},{"issue":"12","key":"10.1016\/j.mcna.2021.06.008_bib103","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1111\/jdv.15081","article-title":"Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis","volume":"32","author":"Gupta","year":"2018","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.mcna.2021.06.008_bib104","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1749-6632.1995.tb31386.x","article-title":"Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity","volume":"761","author":"Muhn","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.mcna.2021.06.008_bib105","doi-asserted-by":"crossref","first-page":"f5298","DOI":"10.1136\/bmj.f5298","article-title":"Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis","volume":"347","author":"Stegeman","year":"2013","journal-title":"Bmj"},{"key":"10.1016\/j.mcna.2021.06.008_bib106","first-page":"Cd001125","article-title":"Cyproterone acetate for hirsutism","volume":"4","author":"Van der Spuy","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.mcna.2021.06.008_bib107","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/lsm.22512","article-title":"Low-level laser therapy as a treatment for androgenetic alopecia","volume":"49","author":"Afifi","year":"2017","journal-title":"Lasers Surg Med"},{"issue":"5","key":"10.1016\/j.mcna.2021.06.008_bib108","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0190-9622(03)01568-8","article-title":"Hair transplanting: an important but often forgotten treatment for female pattern hair loss","volume":"49","author":"Unger","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.mcna.2021.06.008_bib109","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/jocd.12331","article-title":"Platelet-rich plasma for androgenetic alopecia: Does it work? Evidence from meta analysis","volume":"16","author":"Giordano","year":"2017","journal-title":"J\u00a0Cosmet Dermatol"},{"issue":"12","key":"10.1016\/j.mcna.2021.06.008_bib110","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/BF01660957","article-title":"[Therapy of hirsutism in females with adrenal enzyme defects of steroid hormone biosynthesis: comparison of dexamethasone with cyproterone acetate]","volume":"68","author":"Frank-Raue","year":"1990","journal-title":"Klin Wochenschr"},{"issue":"12","key":"10.1016\/j.mcna.2021.06.008_bib111","first-page":"3412","article-title":"Comparison of a gonadotropin-releasing hormone agonist and a low dose oral contraceptive given alone or together in the treatment of hirsutism","volume":"80","author":"Heiner","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.mcna.2021.06.008_bib112","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0015-0282(16)57593-1","article-title":"Depot leuprolide acetate versus danazol for treatment of pelvic endometriosis: changes in vertebral bone mass and serum estradiol and calcitonin","volume":"63","author":"Dawood","year":"1995","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.mcna.2021.06.008_bib113","first-page":"Cd010334","article-title":"Interventions for hirsutism (excluding laser and photoepilation therapy alone)","volume":"2015","author":"van Zuuren","year":"2015","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712521000948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712521000948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:46:07Z","timestamp":1758419167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712521000948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":113,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0025712521000948"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2021.06.008","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Practical Approach to Hyperandrogenism in Women","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2021.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}